120,177 Shares in Phreesia, Inc. $PHR Bought by Palogic Value Management L.P.

Palogic Value Management L.P. purchased a new stake in shares of Phreesia, Inc. (NYSE:PHR) during the 2nd quarter, HoldingsChannel reports. The firm purchased 120,177 shares of the company’s stock, valued at approximately $1,237,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PHR. Pale Fire Capital SE purchased a new stake in shares of Phreesia during the 1st quarter worth about $72,481,000. BlackRock Inc. acquired a new stake in shares of Phreesia during the 2nd quarter valued at about $72,234,000. Granahan Investment Management LLC increased its stake in shares of Phreesia by 73.8% in the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after purchasing an additional 1,018,987 shares in the last quarter. Prosight Management LP purchased a new position in shares of Phreesia in the 4th quarter valued at about $16,533,000. Finally, Millennium Management LLC raised its holdings in Phreesia by 730.7% in the 3rd quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after purchasing an additional 936,033 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

NYSE:PHR opened at $11.58 on Thursday. Phreesia, Inc. has a one year low of $7.77 and a one year high of $32.76. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market cap of $715.78 million, a PE ratio of 77.20 and a beta of 0.85. The stock has a 50 day moving average price of $10.92 and a 200 day moving average price of $10.49.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. The company had revenue of $130.94 million for the quarter, compared to analyst estimates of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.07) earnings per share. Equities research analysts expect that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent analyst reports. Barclays reiterated an “equal weight” rating and set a $10.00 price target (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Piper Sandler cut Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price objective for the company. in a research report on Thursday, May 28th. Canaccord Genuity Group reduced their target price on Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, May 28th. Weiss Ratings upgraded Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, July 20th. Finally, Citigroup reissued a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $16.65.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.